BioNexus Gene Lab Common Stock Net 2019-2025 | BGLC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BioNexus Gene Lab common stock net from 2019 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BioNexus Gene Lab common stock net from 2019 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$151.4B
CVS Health (CVS)	$89.8B
Elevance Health (ELV)	$69.8B
Cencora (COR)	$58.9B
DiDi Global (DIDIY)	$28.4B
Labcorp Holdings (LH)	$23.1B
Natera (NTRA)	$22B
BioMerieux (BMXMF)	$17.6B
EUROFINS SCIENT (ERFSF)	$15.7B
ICON (ICLR)	$14.6B
Medpace Holdings (MEDP)	$13.1B
Solventum (SOLV)	$12.6B
CochLear (CHEOY)	$12.5B
Viatris (VTRS)	$12.4B
Revvity (RVTY)	$10.6B
Caris Life Sciences,�Inc (CAI)	$9.9B
Sonic Healthcare (SKHHY)	$9.2B
Avantor (AVTR)	$8.8B
Charles River Laboratories (CRL)	$7.9B
HealthEquity (HQY)	$7.7B
Bausch + Lomb (BLCO)	$5.1B
Sotera Health (SHC)	$4.6B
BrightSpring Health Services (BTSG)	$4.2B
Amplifon S.p.A (AMFPF)	$3.9B
GeneDx Holdings (WGS)	$3.5B
Surgery Partners (SGRY)	$3.1B
Alignment Healthcare (ALHC)	$3B
Concentras Parent (CON)	$3B
Organon (OGN)	$2.4B
Premier (PINC)	$2.1B